Status:
NOT_YET_RECRUITING
Topo-Pachymetric Customized Accelerated Epi-On Vs Accelerated Epi-Off Corneal Cross Linking in Keratoconus Management
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Amount of Corneal Flattening (Kmax Flattening)
Change in the Endothelial Cell Count
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to compare the clinical effectiveness and safety of Topo-Pachymetric Customized Accelerated Epithelium-On (aCFXL) to Standard Accelerated Epithelium-Off (aCXL) Corneal C...
Eligibility Criteria
Inclusion
- Age: 18 years or older
- Corrected distance visual acuity (CDVA) of ≥ 0.3 Snellen.
- Central corneal thickness (de-epithelialized) of ≥ 400 micron.
- Corneal endothelial count of ≥ 2000.
Exclusion
- Previous eye surgery
- The presence of lesions other than keratoconus, central or paracentral scaring
- History of Cross linking
- History of viral keratitis
- Connective tissue diseases
- Pregnancy or lactation during the study.
- The presence of nystagmus
Key Trial Info
Start Date :
August 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2025
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT06549387
Start Date
August 15 2024
End Date
April 30 2025
Last Update
August 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Al Ainy
Cairo, Egypt